Skip to main content
SpringerLink
Log in

The Pathogenesis of Ovarian Hyperstimulation Syndrome: A Continuing Enigma

  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose: Our purpose was to review the available literature concerning the pathogenesis of ovarian hyperstimulation syndrome and, in light of the most recent information, to attempt to provide further insight on this iatrogenic complication associated with the induction of ovulation.

Methods: Published studies related to this topic were identified through a computerized bibliographic search.

Conclusions: The exact mechanism for the development of ovarian hyperstimulation syndrome is still obscure. It is well established that the syndrome is associated with the process of ovulation induced by either luteinizing hormone or human chorionic gonadotropin. Following ovulation, one or more substances produced by the ovary are liberated in excess, increasing capillary permeability, resulting in the clinical features of the syndrome. It may well be that the syndrome is not triggered by a single mechanism but by the production and secretion of several substances acting in concert. These may include prostaglandins, cytokines, the ovarian rennin–angiotensin system, vascular endothelial growth factor, and nitric oxide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Schenker JG, Weinstein D: Ovarian hyperstimulation syndrome: A current survey. Fertil Steril 1978;30:255–268

    Google Scholar 

  2. Schenker JG: Prevention and treatment of ovarian hyperstimulation. Hum Reprod 1993;8:653–659

    Google Scholar 

  3. Haning RV Jr, Austin CW, Carlson IH, Kuzma DL, Shapiro SS, Zweibel WJ: Plasma estradiol is superior to ultrasound and urinary estradiol glucuronide as a predictor of ovarian hyperstimulation during induction of ovulation with menotropins. Fertil Steril 1983;40:31–36

    Google Scholar 

  4. Rabau E, David A, Serr DM, Mashiach S, Lunenfeld B: Human menopausal gonadotropins for anovulation and sterility: Results of 7 years of treatment. Am J Obstet Gynecol 1967;98:92–98

    Google Scholar 

  5. Tulandi T, McInnes RA, Arronet GH: Ovarian hyperstimulation syndrome following ovulation induction with human menopausal gonadotropin. Int J Fertil 1984;29:113–117

    Google Scholar 

  6. Golan A, Ron-El R, Herman A, Weinraub Z, Soffer Y, Caspi E: Ovarian hyperstimulation syndrome following D-Trp-6 luteinizing hormone-releasing hormone microcapsules and menotropin for in vitro fertilization. Fertil Steril 1988;50:912–916

    Google Scholar 

  7. Borenstein R, Elhalal U, Lunenfeld B, Schwartz ZS: Severe ovarian hyperstimulation syndrome: A re-evaluated therapeutic approach. Fertil Steril 1989;51:791–795

    Google Scholar 

  8. Herman A, Ron-El R, Golan A, Raziel A, Soffer Y, Caspi E: Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins. Fertil Steril 1990;53:92–96

    Google Scholar 

  9. Forman RG, Frydman R, Egan D, Ross C, Barlow DH: Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: A European series and a proposal for prevention. Fertil Steril 1990;53:502–509

    Google Scholar 

  10. Smitz J, Camus M, Devroey P, Erard P, Wisanto A, Van Steirteghem AC: Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/HMG superovulation for in-vitro fertilization. Hum Reprod 1990;5:933–937

    Google Scholar 

  11. Rizk B, Tan SL, Morcos S, Riddle A, Brinsden P, Mason BA, et al.: Heterotopic pregnancies after in vitro fertilization and embryo transfer. Am J Obstet Gynecol 1991;164:161–164.

    Google Scholar 

  12. MacDougall MJ, Tan SL, Jacobs HS: In-vitro fertilization and the ovarian hyperstimulation syndrome. Hum Reprod 1992;7:597–600

    Google Scholar 

  13. Southan AL, Janovsky NA: Massive ovarian hyperstimulation with clomiphene citrate. JAMA 1962;200:443

    Google Scholar 

  14. Scommegna A, Lash SR: Ovarian hyperstimulation, massive ascites, and singleton pregnancy after clomiphene. JAMA 1969;207:753–755

    Google Scholar 

  15. Pappas GD, Blanchette EJ: Transport of colloidal particles fron small blood vessels correlated with cyclic changes in permeability. Invest Ophthalmol 1965;4:1026–1036

    Google Scholar 

  16. Pride SM, James C, Ho Yuen B: The ovarian hyperstimulation syndrome. Semin Reprod Endocrinol 1990;8:247–260

    Google Scholar 

  17. Pellicer A, Miro F, Sampaio M, Gomez E, Bonilla-Musoles FM: In vitro fertilization as a diagnostic and therapeutic tool in a patient with partial 17,20-desmolase deficiency. Fertil Steril 1990;55:970–975

    Google Scholar 

  18. Meirow D, Schenker JG, Rosler A: Ovarian hyperstimulation syndrome with low estradiol in non classic 17alpha-hydroxylase, 17,20-lyase deficiency: What is the role of oestrogens? Hum Reprod 1996;11:2119–2121

    Google Scholar 

  19. Knox GE: Antihistamine blockage of the ovarian hyperstimulation syndrome. Am J Obstet Gynecol 1974;118:992–999

    Google Scholar 

  20. Gregely RZ, Paldi E, Erlik Y, Makler A: Treatment of ovarian hyperstimulation syndrome by antihistamine. Obstet Gynecol 1976;47:83–85

    Google Scholar 

  21. Pride SM, Ho Yuen B, Moon YS: Clinical, endocrinologic, and intraovarian prostaglandin F responses tp H-1 receptor blockade in the ovarian hyperstimulation syndrome: studies in the rabbit model. Am J Obstet Gynecol 1984;148:670–674

    Google Scholar 

  22. Erlik Y, Naot Y, Friedman M, Ben-David E, Paldi E: Histamine levels in ovarian hyperstimulation syndrome. Obstet Gynecol 1979;53:580–582

    Google Scholar 

  23. Katz Z, Lancet M, Borenstein R, Chemke J: Absence of teratogenicity of indomethacin in ovarian hyperstimulation syndrome. Int J Fertil 1984;29:186–188

    Google Scholar 

  24. Yuen BH, McComb P, Sy L, Lewis J, Cannon W: Plasma prolactin, human chorionic gonadotropin, estradiol, testosterone, and progesterone in ovarian hyperstimulation syndrome. Am J Obstet Gynecol 1979;133:316–320

    Google Scholar 

  25. Raabe MA, McCoshen JA: Epithelial regulation of prolactin effect on amniotic permeability. Am J Obstet Gynecol 1986;154:130–134

    Google Scholar 

  26. Niederer W, Richardson BP, Donatsch P: Hormonal control of aqueous humour production. Exp Eye Res 1975;20:329–340

    Google Scholar 

  27. Leung P, Ho Yuen B, Moon YS: Effect of prolactin in an experimental model of the ovarian hyperstimulation syndrome. Am J Obstet Gynecol 1983;145:847–849

    Google Scholar 

  28. Navot D, Margalioth EJ, Laufer N, Birkenfeld A, Relou A, Rosler A, et al.: Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome. Fertil Steril 1987;48:57–61

    Google Scholar 

  29. Itskovitz J, Sealey JE: Ovarian prorenin renin-angiotensin system. Obstet Gynecol Surv 1987;42:545–551

    Google Scholar 

  30. Ezra Y, Simon A, Yaron A, Laufer N, Navot D: Angiotensin-I-converting enzyme and its correlation with human follicular fluid steroids. Eur J Obstet Gynecol Reprod Biol 1992;44:71–75

    Google Scholar 

  31. Morris RS, Paulson RJ: The ovarian renin angiotensin system: Recent advances and their relationship to assisted reproductive technologies. Assist Reprod Rev 1993;3:2–6

    Google Scholar 

  32. Delbaere A, Bergmann PJM, Gervy-Decoster C, Staroukine M, Englert Y: Angiotensin II immunoreactivity is elevated in ascites during severe ovarian hyperstimulation syndrome: Implication for pathophysiology and clinical management. Fertil Steril 1994;62:731–737

    Google Scholar 

  33. Fernadez LA, Twickler J, Mead A: Neovascularization produced by angiotensin II. J Lab Clin Med 1985;105:141–145

    Google Scholar 

  34. Paulson RJ, Do YS, Hsueh WA, Eggena P, Lobo RA: Ovarian renin production in vitro and in vivo: Characterization and clinical correlation. Fertil Steril 1989;51:634–638

    Google Scholar 

  35. Alexander RW, Gimborne MA Jr: Stimulation of prostaglandin E synthesis in cultured human umbilical vein smooth muscle cells. Proc Natl Acad Sci USA 1976;73:1617–1620

    Google Scholar 

  36. Robertson AL, Khairallah PA: Effects of angiotensin II and some analogues on vascular permeability in the rabbit. Circ Res 1972;31:923–931

    Google Scholar 

  37. Morris RS, Wong IL, Paulson RJ: Angiotensin-converting enzyme-inhibition of the gonadotropin-stimulated rabbit—Effect on estradiol production. J Assist Reprod Genet 1995;12:326–329

    Google Scholar 

  38. Morris RS, Wong IL, Kirkman E, et al.: Inhibition of ovarian-derived prorenin to angiotensin cascade in the treatment of ovarian hyperstimulation syndrome. Hum Reprod 1995;10:1355–1358

    Google Scholar 

  39. Sifton DW (ed): Physician Desk Reference. Montvale, NJ, Medical Economics, 1994, pp 1556–1557

    Google Scholar 

  40. Briggs GG, Freeman RK, Yaffe SJ (eds): Drugs in Pregnancy and Lactation, 3rd ed. Baltimore, Williams and Wilkins, 1990, pp 83–87, 232–235

    Google Scholar 

  41. Pellicer A, Palumbo A, DeCherney AH, Naftolin F: Blockade of ovulation by an angiotensin antagonist. Science 1988;240:1660–1661

    Google Scholar 

  42. Adashi EY: The potential relevance of cytokines to ovarian physiology: The emerging role of resident ovarian cells of the white blood cell series. Endocr Rev 1990;11:454–464

    Google Scholar 

  43. Dinarello CA: Interleukin-1 and its related cytokines. Adv Immunol 1989; 44:153–205

    Google Scholar 

  44. Loukides JA, Loy RA, Edwards R, Honig J, VisintinI, Polan ML: Human follicular fluids contain tissue macrophages. J Clin Endocrinol Metab 1990; 71:1363–1367

    Google Scholar 

  45. Arici A, Oral E, Bukulmez O, Buradagunta S, Engin O, Olive DL: Interleukin-8 expression and modulation in human preovulatory follicles and ovarian cells. Endocrinology 1996;137:3762–3769

    Google Scholar 

  46. Sirotkin AV, Luck MR: Potential leukocyte attractants in the bovine periovulatory ovary. Reprod Nutr Dev 1995;35:675–683

    Google Scholar 

  47. Cavender JL, Murdoch WJ: Morphological studies of the microcirculatory system of periovulatory ovine follicles. Biol Reprod 1988;39:989–997

    Google Scholar 

  48. Dinarello CA: Interleukin-1 and interleukin-1 antagonism. Blood 1991;77:1627–1652

    Google Scholar 

  49. Friedlander MA, Loret de Mola JR, Goldfarb JM: Elevated levels of interleukin-6 in ascites and serum from women with ovarian hyperstimulation syndrome. Fertil Steril 1993;60:826–833

    Google Scholar 

  50. Hurwitz A, Loukides J, Ricciarelli E, Botero L, Katz E, McAllister JM, Garcia JE, Rohan R, Adashi EY, Hernandez ER: Human intraovarian interleukin-1 (IL-1) system: highly compartmentalized and hormonally dependent regulation of the genes encoding IL-1, its receptor, and its receptor antagonist. J Clin Invest 1992;89:1746–1754

    Google Scholar 

  51. Revel A, Barak V, Lavy Y, Anteby E, Amit A, Finci-Yeheskel Z, et al.: Characterization of intraperitoneal cytokines and nitrites in women with severe ovarian hyperstimulation syndrome. Fertil Steril 1996;66:66–71

    Google Scholar 

  52. Abramov Y, Schenker JG, Lewin A, Friedler S, Nisman B, Barak V: Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome. Hum Reprod 1996;11:1381–1386

    Google Scholar 

  53. Orvieto R, Ben-Rafael Z: The immune system in severe ovarian hyperstimulation syndrome. Isr J Med Sci 1996;32:1180–1182

    Google Scholar 

  54. Motro B, Itin A, Sachs I, Keshet E: Pattern of IL-6 gene expression in vivo suggests a role for this cytokine in angiogenesis. J Cell Biol 1990;87:3092–3096

    Google Scholar 

  55. Veale D, Yanni G, Bresnihan B, FitzGerald O: Production of angiotensin converting enzyme by rheumatoid synovial membrane. Ann Rheum Dis 1992;51:476–480

    Google Scholar 

  56. Watson JM, Sensintaffar JL, Berek JS, Martinez-Maza O: Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res 1990;50:6959–6965

    Google Scholar 

  57. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ: Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 1996;271:736–741

    Google Scholar 

  58. Loret de Mola JR, Flores JP, Baumgardner GP, Goldfarb JM, Gindlesperger V, Friedlander MA: Elevated interleukin-6 levels in the ovarian hyperstimulation syndrome: Ovarian immunohistochemical localization of interleukin-6 signal. Obstet Gynecol 1996;87:581–587

    Google Scholar 

  59. Kishimoto T: The biology of IL-6. Blood 1989;74:1–10

    Google Scholar 

  60. Terranova PF, Sancho-Tello M, Hunter VG: TNF and ovarian function. In The Ovary, EY Adashi, CK Leung, (eds). New York, Raven Press, 1993, pp. 395–411

    Google Scholar 

  61. Loret de Mola JR, Baumgardner GP, Goldfarb JM, Friedlander MA: Ovarian hyperstimulation syndrome: Pre-ovulatory serum concentrations of interleukin-6, interleukin-1 receptor antagonist and tumour necrosis factor-alpha cannot predict its occurrence. Hum Reprod 1996;11:1377–1380

    Google Scholar 

  62. Robertson D, Selleck K, Suikkari AM, Hurley V, Moohan J, Healy D: Urinary vascular endothelial growth factor concentrations in women undergoing gonadotrophin treatment. Hum Reprod 1995;10:2478–2482

    Google Scholar 

  63. Neulen J, Yan Z, Raczek S, Weindel K, Keck C, Weich HA, et al.: Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: Importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 1995;80:1967–1971

    Google Scholar 

  64. McClure N, Healy DI, Rogers PA, Sullivan J, Beaton L, Haning Jr RV, et al.: Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 1994;344:235–236

    Google Scholar 

  65. Krasnow JS, Berga SL, Guzick DS, Zeleznik AJ, Yeo KT: Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: A preliminary report. Fertil Steril 1996;65:552–555

    Google Scholar 

  66. Abramov Y, Brak V, Nisman B, Schenker JG: Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil Steril 1997;67:261–265

    Google Scholar 

  67. Van Voorhis BJ, Dunn MS, Snyder GD, Weiner CP: Nitric oxide: An autocrine regulator of human granulosa-luteal cell steroidogenesis. Endocrinology 1994;135:1799–1806

    Google Scholar 

  68. Shukovski L, Tsafriri A: The involvement of nitric oxide in the ovulatory process in the rat. Endocrinology 1994;135:2287–2290

    Google Scholar 

  69. Ben Shlomo I, Kokia E, Jackson MJ, Adashi EY, Payne DW: Interleukin-1 beta stimulates nitrite production in the rat ovary: Evidence for heterologous cell-cell interaction and for insulinmediated regulation of the inducible isoform of nitric oxide synthase. Biol Reprod 1994;51:310–318

    Google Scholar 

  70. Fillep JG, Foldes-Filep E, Sirois P: Nitric oxide modulates vascular permeability in the rat coronary circulation. Br J Pharmacol 1993;108:323–326

    Google Scholar 

  71. Kubes P, Granger DN: Nitric oxide modulates microvascular permeability. Am J Physiol 1992;262:611–615

    Google Scholar 

  72. McCall TB, Boughton-Smith NK, Palmer RM, Whittle BJ, Moncada S: Synthesis of nitric oxide from L-arginine by neutrophils. Biochem J 1989;261:293–296

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Hadassah University Hospital, Mount Scopus, Jerusalem, Israel

    Alexander Simon, Ariel Revel, Arye Hurwitz & Neri Laufer

Authors
  1. Alexander Simon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ariel Revel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Arye Hurwitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Neri Laufer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Simon, A., Revel, A., Hurwitz, A. et al. The Pathogenesis of Ovarian Hyperstimulation Syndrome: A Continuing Enigma. J Assist Reprod Genet 15, 202–209 (1998). https://doi.org/10.1023/A:1023052419627

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1023052419627

Search

Navigation